Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.68 |
| ▸ | NPC1 | O15118 | 9/20 | 0.68 |
| ▸ | RAB9A | P51151 | 9/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.68 |
| ▸ | HPGD | P15428 | 8/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.68 |
| ▸ | TP53 | P04637 | 6/20 | 0.68 |
| ▸ | CASP3 | P42574 | 3/20 | 0.61 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.61 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.61 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | SNCA | P37840 | 1/20 | 0.59 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 5/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 5/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29881920 | 1.00 | KDM4E (0.68) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL318305 | 1.00 | KDM4E (0.68) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL28820725 | 0.94 | NPC1 (0.61) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL29360251 | 0.93 | KDM4E (0.79) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL385476 | 0.93 | KDM4E (0.79) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL385477 | 0.93 | KDM4E (0.79) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL1248209 | 0.92 | KDM4E (0.82) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL15951017 | 0.89 | SMN1; SMN2 (0.54) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL15951018 | 0.89 | SMN1; SMN2 (0.54) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL27791454 | 0.89 | KDM4E (0.54) | KDM4ESMN1; SMN2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101120046-B | Molded article exhibiting multi-color effects, associated lighting device and resin | ARKEMA FRANCE | 2011-02-23 | — | — | CN | claimed |
| US-20080214706-A1 | Moulded Object Exhibiting a Polychromatic Effect, Associated Light Device and Resin | ARKEMA FRANCE (FR) | 2008-09-04 | — | — | US | claimed |
| EP-1848763-B1 | MOULDED OBJECT EXHIBITING A POLYCHROMATIC EFFECT, ASSOCIATED LIGHT DEVICE AND RESIN | ARKEMA FRANCE (FR) | 2008-04-16 | — | — | EP | claimed |
| CN-101120046-A | Molded article exhibiting multi-color effects, associated lighting device and resin | ARKEMA FRANCE (FR) | 2008-02-06 | — | — | CN | claimed |
| EP-1848763-A1 | MOULDED OBJECT EXHIBITING A POLYCHROMATIC EFFECT, ASSOCIATED LIGHT DEVICE AND RESIN | Arkema France (FR) | 2007-10-31 | — | — | EP | claimed |
| WO-2006087241-A1 | MOULDED OBJECT EXHIBITING A POLYCHROMATIC EFFECT, ASSOCIATED LIGHT DEVICE AND RESIN | ARKEMA FRANCE (FR) | 2006-08-24 | — | — | WO | claimed |
| US-5142343-A | An electroluminiscent oligomer semiconductor zone and an insulator zone containing a light-emitting zone sandwiched between electrodes | IDEMITSU KOSAN CO., LTD. (JP) | 1992-08-25 | — | — | US | claimed |
| US-12303582-B2 | Composition for the treatment of nail fungus | OYSTERSHELL NV (BE) | 2025-05-20 | — | — | US | disclosed |
| US-11871590-B2 | Thin film of metal oxide, organic electroluminescent device including thin film, photovoltaic cell including thin film, and manufacturing method of thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2024-01-09 | — | — | US | disclosed |
| US-20210343961-A1 | THIN FILM OF METAL OXIDE, ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THIN FILM, PHOTOVOLTAIC CELL INCLUDING THIN FILM, AND MANUFACTURING METHOD OF THIN FILM | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-11-04 | — | — | US | disclosed |
| US-20210299022-A1 | COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS | OYSTERSHELL NV (BE) | 2021-09-30 | — | — | US | disclosed |
| EP-3884933-A1 | COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS | Oystershell NV (BE) | 2021-09-29 | — | — | EP | disclosed |
| US-11094909-B2 | Thin film of metal oxide, organic electroluminescent device including the thin film, photovoltaic cell including the thin film and organic photovoltaic cell including the thin film | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-08-17 | — | — | US | disclosed |
| US-5314775-A | Electroluminescence device as charge transfer compound | MINOLTA CAMERA KABUSHIKI KAISHA (JP) | 1994-05-24 | — | — | US | disclosed |
| EP-0563811-A1 | Silanamine derivative and process for the production thereof, and organical EL device using the said silanamine derivative | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-10-06 | — | — | EP | disclosed |
| EP-0548366-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-06-30 | — | — | EP | disclosed |
| US-5142343-A | An electroluminiscent oligomer semiconductor zone and an insulator zone containing a light-emitting zone sandwiched between electrodes | IDEMITSU KOSAN CO., LTD. (JP) | 1992-08-25 | — | — | US | disclosed |
| EP-0439627-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1991-08-07 | — | — | EP | disclosed |
| EP-0120673-B1 | ORGANIC ELECTROLUMINESCENT DEVICES HAVING IMPROVED POWER CONVERSION EFFICIENCIES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1988-06-01 | — | — | EP | disclosed |
| US-4539507-A | CHARGE TRANSFER COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1985-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12303582-B2 | Composition for the treatment of nail fungus | DPM1, PIK3C3, ETF1 | KDM4E 1587/4885SMN1; SMN2 3362/4885NPC1 1932/4885 |
| US-20210299022-A1 | COMPOSITION FOR THE TREATMENT OF NAIL FUNGUS | DPM1, PIK3C3, ETF1 | KDM4E 1587/4885SMN1; SMN2 3362/4885NPC1 1932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.